Decoy Therapeutics Inc. (DCOY) News
Track canonical SquawkNews coverage tagged to DCOY, Decoy Therapeutics Inc.. This hub brings together deduplicated headlines about alpaca us equities, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 16 indexed stories across 8 publication days and is ordered by the same first-publication timeline used by LiveCast.
L
Decoy Therapeutics, Inc. (DCOY) Preclinical PK Supports Once-Weekly Intranasal Dosing
Decoy Therapeutics reported preclinical PK data showing a single intranasal dose of DCOY-CoV maintained drug levels above designed therapeutic concentrations in nasal mucosa and lung tissue for up to 7 days. The program
NEWS | Sep 29, 2026, 11:31 AM UTC
L
Decoy Therapeutics Reports Preclinical Data Supporting Once-Weekly Intranasal Dosing for DCOY-CoV Program
Once-Weekly Intranasal Potential: Preclinical PK data demonstrate single-dose drug levels sustained above designed therapeutic concentrations for up to 7 days in nasal mucosal and lung tissue.Addressing Endemic Coronavir
NEWS | Sep 29, 2026, 11:30 AM UTC
L
Decoy Therapeutics Raises $3.85 Million via Warrant Inducement; Issues 5-Year New Warrants
Decoy Therapeutics entered into a warrant inducement agreement to secure immediate cash exercises and boost liquidity. An existing holder exercised 1,184,434 Series B warrants after the exercise price was cut to $3.25, g
NEWS | Sep 23, 2026, 09:15 PM UTC
L
DCOY - Decoy Therapeutics, Inc. Issues Correction to Warrant Inducement Transaction Press Release
DCOY - Decoy Therapeutics, Inc. Issues Correction to Warrant Inducement Transaction Press Release
NEWS | Sep 22, 2026, 10:15 PM UTC
L
DCOY - /C O R R E C T I O N -- Decoy Therapeutics, Inc/
DCOY - /C O R R E C T I O N -- Decoy Therapeutics, Inc/
NEWS | Sep 22, 2026, 06:04 PM UTC
L
DCOY - Decoy Therapeutics, Inc. Announces a Warrant Inducement Transaction for $3.85 Million in Gross Proceeds Priced At-The-Market under Nasdaq Rules
DCOY - Decoy Therapeutics, Inc. Announces a Warrant Inducement Transaction for $3.85 Million in Gross Proceeds Priced At-The-Market under Nasdaq Rules
NEWS | Sep 22, 2026, 04:53 PM UTC
L
DCOY - Decoy Therapeutics Exploring Pan-Filovirus Program via FDA Animal Rule Pathway and Non-Dilutive Funding
DCOY - Decoy Therapeutics Exploring Pan-Filovirus Program via FDA Animal Rule Pathway and Non-Dilutive Funding
REGULATION | Sep 22, 2026, 11:31 AM UTC
M
Decoy Therapeutics explores pan-filovirus program via FDA Animal Rule
Decoy Therapeutics said its next-generation D-MAVs showed potent in-vitro activity against Ebola Zaire and Marburg, and that it is exploring a pan-filovirus program using the FDA Animal Rule pathway and non-dilutive fund
EQUITY | Sep 22, 2026, 11:30 AM UTC
L
Decoy Therapeutics CEO to present at 2026 disruptive growth conference
Rick Pierce, Chief Executive Officer, will deliver an investor presentation on Thursday, September 10 in New York, for Decoy Therapeutics at the Moody Capital Solutions 2026 Disruptive Growth & Life Sciences Conference.
EQUITY | Sep 08, 2026, 01:06 PM UTC
M
Decoy Therapeutics Expands Intellectual Property
Decoy Therapeutics expands IP portfolio
EQUITY | Aug 03, 2026, 01:01 PM UTC
L
DCOY DCOY - Decoy Therapeutics Announces Breakthrough In Vitro Activity Against Ebola Zaire, Expanding D-MAV™ Platform into High Consequence
DCOY DCOY - Decoy Therapeutics Announces Breakthrough In Vitro Activity Against Ebola Zaire, Expanding D-MAV™ Platform into High Consequence Global Health Threats
EQUITY | Jul 27, 2026, 01:01 PM UTC
L
12 Health Care Stocks Moving In Tuesday's Intraday Session
Gainers Creative Medical Tech (NASDAQ: CELZ ) stock moved upwards by 242.5% to $2.77 during Tuesday's regular session. The market value of their outstanding shares is at $2.9 million. Cuprina Holdings (Cayman) (NASDAQ: C
EQUITY | Jun 30, 2026, 05:05 PM UTC
L
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Gainers Abivax (NASDAQ: ABVX ) shares increased by 36.0% to $130.74 during Tuesday's pre-market session. The company's market cap stands at $7.6 billion. Cuprina Holdings (Cayman) (NASDAQ: CUPR ) shares moved upwards by
EQUITY | Jun 30, 2026, 12:05 PM UTC
H
Why AeroVironment Shares Are Trading Higher By Over 21%; Here Are 20 Stocks Moving Premarket
Shares of AeroVironment, Inc. (NASDAQ: AVAV ) rose sharply in pre-market trading after the company reported better-than-expected financial results for the fourth quarter of fiscal 2026. AeroVironment guided for fiscal 20
EARNINGS | Jun 30, 2026, 10:10 AM UTC
H
Crude Oil Gains 2%; Comcast Shares Spike Higher
U.S. stocks traded higher midway through trading, with the Dow Jones index gaining more than 200 points on Monday. The Dow traded up 0.44% to 52,105.66 while the NASDAQ rose 1.33% to 25,634.54. The S&P 500 also rose, gai
CENTRAL_BANK | Jun 29, 2026, 04:30 PM UTC
H
Why Universe Pharmaceuticals Shares Are Trading Higher By Around 228%; Here Are 20 Stocks Moving Premarket
Shares of Universe Pharmaceuticals Inc (NASDAQ: UPC ) rose sharply in pre-market trading after the company announced it will acquire Best Praise International for $10.75 million. Universe Pharmaceuticals shares jumped 22
RATES | Jun 29, 2026, 11:03 AM UTC